AKTX
Akari Therapeutics
AKTX
AKTX
16 hedge funds and large institutions have $1.71M invested in Akari Therapeutics in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
+4
Holders Change %
+33.33%
% of All Funds
0.25%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Cerity Partners
New York
|
+$54.9K |
2 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$36.8K |
3 |
Renaissance Technologies
New York
|
+$5.89K |
4 |
UBS Group
Zurich,
Switzerland
|
+$4.16K |
5 |
VF
Virtu Financial
New York
|
+$3K |
Top Sellers
1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$93.5K |
2 |
Millennium Management
New York
|
-$21.6K |